cétuximab (ERBITUX°) et cancers des voies aérodigestives récidivants ou métastasés Des résultats trop mitigés
- Other title
- Cetuximab for metastastic or recurrent head and neck cancers : a critical study (en)
- Source
La Revue Prescrire. 2009, Vol 29, Num 308 ; p. 419 ; ref : 5 ref
- ISSN
- 0247-7750
- Scientific domain
- General medicine general surgery; Pharmacology drugs
- Publisher
- Association Mieux prescrire, Paris
- Publication country
- France
- Document type
- Article
- Language
- French
- Keyword (fr)
- Anticancéreux Cancer de la tête et du cou Chimiothérapie Cétuximab Efficacité traitement Fiche technique Homme Immunomodulateur Monographie Métastase Toxicité Tumeur maligne Voie intraveineuse Anti-EGFR Anticorps monoclonal Cancer Pathologie ORL Récepteur facteur croissance épiderme Traitement
- Keyword (en)
- Antineoplastic agent Head and neck cancer Chemotherapy Cetuximab Treatment efficiency Technical card Human Immunomodulator Monograph Metastasis Toxicity Malignant tumor Intravenous administration Monoclonal antibody Cancer ENT disease Epidermal growth factor receptor Treatment
- Keyword (es)
- Anticanceroso Cáncer de cabeza y cuello Quimioterapia Cetuximab Eficacia tratamiento Ficha técnica Hombre Inmunomodulador Monografía Metástasis Toxicidad Tumor maligno Vía intravenosa Anticuerpo monoclonal Cáncer ORL patología Receptor del factor de crecimiento epidérmico Tratamiento
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B10 Otorhinolaryngology. Stomatology / 002B10A Otorhinolaryngology (head neck, general aspects and miscellaneous) / 002B10A01 Tumors
- Discipline
- Otorhinolaryngology. Stomatology Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 21473949
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:117:\"c\u00e9tuximab (ERBITUX\u00b0) et cancers des voies a\u00e9rodigestives r\u00e9cidivants ou m\u00e9tastas\u00e9s Des r\u00e9sultats trop mitig\u00e9s\";s:9:\"\u0000*\u0000jtitle\";s:18:\"La Revue Prescrire\";s:9:\"\u0000*\u0000stitle\";s:11:\"Rev. Prescr\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"29\";s:8:\"\u0000*\u0000issue\";s:3:\"308\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:6:\"p. 419\";s:7:\"\u0000*\u0000issn\";s:9:\"0247-7750\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:117:\"c\u00e9tuximab (ERBITUX\u00b0) et cancers des voies a\u00e9rodigestives r\u00e9cidivants ou m\u00e9tastas\u00e9s Des r\u00e9sultats trop mitig\u00e9s\";s:8:\"\u0000*\u0000place\";s:5:\"Paris\";s:6:\"\u0000*\u0000pub\";s:27:\"Association Mieux prescrire\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:0;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:117:\"c\u00e9tuximab (ERBITUX\u00b0) et cancers des voies a\u00e9rodigestives r\u00e9cidivants ou m\u00e9tastas\u00e9s Des r\u00e9sultats trop mitig\u00e9s\";s:9:\"\u0000*\u0000jtitle\";s:18:\"La Revue Prescrire\";s:9:\"\u0000*\u0000stitle\";s:11:\"Rev. Prescr\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"29\";s:8:\"\u0000*\u0000issue\";s:3:\"308\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:6:\"p. 419\";s:7:\"\u0000*\u0000issn\";s:9:\"0247-7750\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:117:\"c\u00e9tuximab (ERBITUX\u00b0) et cancers des voies a\u00e9rodigestives r\u00e9cidivants ou m\u00e9tastas\u00e9s Des r\u00e9sultats trop mitig\u00e9s\";s:8:\"\u0000*\u0000place\";s:5:\"Paris\";s:6:\"\u0000*\u0000pub\";s:27:\"Association Mieux prescrire\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:0;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:117:\"c\u00e9tuximab (ERBITUX\u00b0) et cancers des voies a\u00e9rodigestives r\u00e9cidivants ou m\u00e9tastas\u00e9s Des r\u00e9sultats trop mitig\u00e9s\";s:9:\"\u0000*\u0000jtitle\";s:18:\"La Revue Prescrire\";s:9:\"\u0000*\u0000stitle\";s:11:\"Rev. Prescr\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"29\";s:8:\"\u0000*\u0000issue\";s:3:\"308\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:6:\"p. 419\";s:7:\"\u0000*\u0000issn\";s:9:\"0247-7750\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:117:\"c\u00e9tuximab (ERBITUX\u00b0) et cancers des voies a\u00e9rodigestives r\u00e9cidivants ou m\u00e9tastas\u00e9s Des r\u00e9sultats trop mitig\u00e9s\";s:8:\"\u0000*\u0000place\";s:5:\"Paris\";s:6:\"\u0000*\u0000pub\";s:27:\"Association Mieux prescrire\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:0;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:117:\"c\u00e9tuximab (ERBITUX\u00b0) et cancers des voies a\u00e9rodigestives r\u00e9cidivants ou m\u00e9tastas\u00e9s Des r\u00e9sultats trop mitig\u00e9s\";s:9:\"\u0000*\u0000jtitle\";s:18:\"La Revue Prescrire\";s:9:\"\u0000*\u0000stitle\";s:11:\"Rev. Prescr\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"29\";s:8:\"\u0000*\u0000issue\";s:3:\"308\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:6:\"p. 419\";s:7:\"\u0000*\u0000issn\";s:9:\"0247-7750\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:117:\"c\u00e9tuximab (ERBITUX\u00b0) et cancers des voies a\u00e9rodigestives r\u00e9cidivants ou m\u00e9tastas\u00e9s Des r\u00e9sultats trop mitig\u00e9s\";s:8:\"\u0000*\u0000place\";s:5:\"Paris\";s:6:\"\u0000*\u0000pub\";s:27:\"Association Mieux prescrire\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:0;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:117:\"c\u00e9tuximab (ERBITUX\u00b0) et cancers des voies a\u00e9rodigestives r\u00e9cidivants ou m\u00e9tastas\u00e9s Des r\u00e9sultats trop mitig\u00e9s\";s:9:\"\u0000*\u0000jtitle\";s:18:\"La Revue Prescrire\";s:9:\"\u0000*\u0000stitle\";s:11:\"Rev. Prescr\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"29\";s:8:\"\u0000*\u0000issue\";s:3:\"308\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:6:\"p. 419\";s:7:\"\u0000*\u0000issn\";s:9:\"0247-7750\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:117:\"c\u00e9tuximab (ERBITUX\u00b0) et cancers des voies a\u00e9rodigestives r\u00e9cidivants ou m\u00e9tastas\u00e9s Des r\u00e9sultats trop mitig\u00e9s\";s:8:\"\u0000*\u0000place\";s:5:\"Paris\";s:6:\"\u0000*\u0000pub\";s:27:\"Association Mieux prescrire\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:0;}"
arXiv access
